UNITED STATES
SECURITIES AND
EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to
Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): November 4, 2010
SELECT MEDICAL HOLDINGS
CORPORATION
SELECT MEDICAL CORPORATION
(Exact name of registrant as specified in its charter)
| Delaware Delaware |
001-34465 001-31441 |
20-1764048 23-2872718 |
||
| (State or other Jurisdiction of Incorporation) | (Commission File Number) | (IRS Employer Identification No.) |
| 4714 Gettysburg Road, P.O.
Box 2034 Mechanicsburg, PA |
17055 | |
| (Address of Principal Executive Offices) | (Zip Code) |
Registrant’s telephone number, including area code: (717) 972-1100
| (Former name or former address if changed since last report.) |
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
o Written
communications pursuant to Rule 425 under the Securities Act (17 CFR
230.425)
o Soliciting material pursuant
to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o Pre-commencement communications pursuant to Rule
14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o Pre-commencement communications pursuant to Rule
13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Item 2.02 Results of Operations and Financial Condition
On November 4, 2010, Select Medical Holdings Corporation (“Holdings”) issued a press release announcing its financial results for its third quarter ended September 30, 2010. A copy of that press release and the attached financial schedules are attached as Exhibit 99.1 to this report and incorporated herein by reference.
Item 7.01 Regulation FD Disclosure
On November 4, 2010, Holdings also announced in the press release attached as Exhibit 99.1 to this report that it has authorized a program to repurchase up to $100,000,000 worth of shares of its common stock. The program will remain in effect until January 31, 2012, unless extended by the Board of Directors of Holdings.
The information in this report (including Exhibit 99.1) is being furnished pursuant to Items 2.02 and 7.01 and shall not be deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934 (the “Exchange Act”) or otherwise subject to the liabilities of that section, nor shall it be deemed to be incorporated by reference in any filing under the Securities Act of 1933 or the Exchange Act.
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits.
| Exhibit Number | Description | |
|
99.1
|
Press Release, dated November 4, 2010, announcing financial results for the third quarter ended September 30, 2010 and approval of a stock repurchase program. |
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrants have duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
SELECT MEDICAL
HOLDINGS CORPORATION
SELECT MEDICAL CORPORATION
| Date: November 4, 2010 |
By: /s/ Michael E.
Tarvin
Michael E. Tarvin
Executive Vice President, General Counsel and
Secretary
EXHIBIT INDEX
| Exhibit Number | Description | |
|
99.1
|
Press Release, dated November 4, 2010, announcing financial results for the third quarter ended September 30, 2010 and approval of a stock repurchase program. |